SARTORIUS AG (SRT.DE) Stock Price, Forecast & Analysis
Europe - FRA:SRT - DE0007165607 - Common Stock
SRT.DE Key Statistics, Chart & Performance
The current stock price of SRT.DE is 183.2 EUR. In the past month the price decreased by -0.65%. In the past year, price decreased by -1.82%.
SRT.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TN8.DE | THERMO FISHER SCIENTIFIC INC | 25.24 | 184.80B | ||
| DAP.DE | DANAHER CORP | 28 | 133.74B | ||
| LO3.DE | LONZA GROUP AG-REG | 35.87 | 42.04B | ||
| QTS.DE | IQVIA HOLDINGS INC | 18.61 | 31.86B | ||
| DIM.PA | SARTORIUS STEDIM BIOTECH | 46.5 | 19.50B | ||
| 56S1.DE | SARTORIUS STEDIM BIOTECH | 48.07 | 20.17B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 50.88 | 17.37B | ||
| ILU.DE | ILLUMINA INC | 28.05 | 16.25B | ||
| ERF.PA | EUROFINS SCIENTIFIC | 16.67 | 10.93B | ||
| ESF0.DE | EUROFINS SCIENTIFIC | 16.96 | 11.12B | ||
| QIA.DE | QIAGEN N.V. | 19.44 | 8.56B | ||
| 1SXP.DE | SCHOTT PHARMA AG& CO KGAA | 19.67 | 2.87B |
Related stock screener links
About SRT.DE
Company Profile
Sartorius AG is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Goettingen, Niedersachsen and currently employs 13,878 full-time employees. Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. The company operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Company Info
SARTORIUS AG
Otto-Brenner-Str. 20
Goettingen NIEDERSACHSEN DE
Employees: 13573
Phone: 495513080
SARTORIUS AG / SRT.DE FAQ
What does SARTORIUS AG do?
Sartorius AG is a DE-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Goettingen, Niedersachsen and currently employs 13,878 full-time employees. Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. The company operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Can you provide the latest stock price for SARTORIUS AG?
The current stock price of SRT.DE is 183.2 EUR. The price decreased by -3.78% in the last trading session.
What is the dividend status of SARTORIUS AG?
SARTORIUS AG (SRT.DE) has a dividend yield of 0.39%. The yearly dividend amount is currently 0.74.
How is the ChartMill rating for SARTORIUS AG?
SRT.DE has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is SARTORIUS AG (SRT.DE) stock traded?
SRT.DE stock is listed on the Deutsche Boerse Ag exchange.
What sector and industry does SARTORIUS AG belong to?
SARTORIUS AG (SRT.DE) operates in the Health Care sector and the Life Sciences Tools & Services industry.
What is SARTORIUS AG worth?
SARTORIUS AG (SRT.DE) has a market capitalization of 13.72B EUR. This makes SRT.DE a Large Cap stock.
SRT.DE Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to SRT.DE. When comparing the yearly performance of all stocks, SRT.DE turns out to be only a medium performer in the overall market: it outperformed 60.02% of all stocks.
SRT.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SRT.DE. SRT.DE has a bad profitability rating. Also its financial health evaluation is rather negative.
SRT.DE Financial Highlights
Over the last trailing twelve months SRT.DE reported a non-GAAP Earnings per Share(EPS) of 4.56. The EPS increased by 59.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 3.8% | ||
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| Debt/Equity | 1.28 |
SRT.DE Forecast & Estimates
8 analysts have analysed SRT.DE and the average price target is 269.28 EUR. This implies a price increase of 46.99% is expected in the next year compared to the current price of 183.2.
For the next year, analysts expect an EPS growth of 23.27% and a revenue growth 5.14% for SRT.DE